ICT Media

Healthcare Decision Support and IBM Watson: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019

  • WIN178744
  • 281 Pages
  • March 2013
  • ICT Media

Product Synopsis



WinterGreen Research announces that it has published a new study Healthcare Decision Support and IBM Watson Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. The 2013 study has 271 pages, 87 tables and figures. Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in response to changing technology, better analytics, and new information systems that leverage natural language, and changing market conditions.



Healthcare decision support markets consist of traditional market participants led by McKesson and Watson from IBM. IBM Watson offers structured and unstructured data in combination. This represents a major breakthrough in what kind of decision support can be offered.



IBM Watson can provide a far more differentiated testing assessment. Watson knows what tests are relevant to further characterize a particular patient condition and what tests are not.



It is a great help to physicians to have an assistant that is able to have read the latest journal articles and is loaded with medical information to recommend what tests may be relevant in a particular situation. Wrong tests, tests that are not useful in a particular situation, account for 30% of the costs of healthcare delivery in the US. This is a lot. To have a new system available that addresses these issues is great.



IBM Watson is initiating a new era of cognitive computing that extends the tabulator and application program intensive enabling new market opportunities based on cognitive performance. Watson is so powerful and so new that the uses for it are not even defined yet. The tools and methods released by natural language computing systems are remarkable. They are very exciting.



Watson is comprised of a core engine. This engine is more powerful than anything that has been designed by humans before. To the credit of IBM, the first purpose that Watson has been put to is to improve healthcare delivery. To those analysts following Watson, there is tremendous promise in the offing.



IBM concentrates on building end to end systems that are able to adapt of market changes. While this may make the IBM product set seem overly heavy in the short run, in the long run, this is of enormous value to clients as proved by the company market leading position in innovation software.



This forecast below is predicated on the assumption that IBM makes available the Watson cognitive computing capability worldwide as a SaaS tool immediately, and people with smart phones learn that for five cents they can access solid medical opinions relating to particular symptoms. This does not turn the consumer into a healthcare provider, but it gives the consumer more power in dealing with the physician and the provider.



Just as the mother that took her child to the doctor this week in February 2013, and said, "I think it is an appendicitis" and the doctor said "No, it is influenza.", after the appendix broke and threatened the life of the child, the mother was angry, the physician was apologetic. With Watson at her side, the mother would have had more credible authority with the doctor.



This scenario really happened to an esteemed marketing manager in Minnesota, USA this week in February 2013. Watson has a lot to offer the consumer, without making the consumer a doctor; it brings more information and authority to the patient - physician interaction.



So also, the physicians gain a valuable assistant at their side when they can access Watson for $60 per physician per month. This cost represents two cents per patient encounter, hardly a blip on the bill to the patient, but lends incredible value to the patient - physician interaction, bringing the latest research to bear on the physician diagnostic and therapeutic decision making process.



Watson can be loaded with the latest research results. No physician can track all the latest medical research; there are intense volumes of it. Any one physician can only hope to read a small portion of what is published in his or her own field. Watson knows it all. It is available to share what it knows at a small fee.



Healthcare decision support markets at $201.7 million in 2012 are anticipated to reach $239 billion by 2019 as consumers access apps and these apps generate micro-payments in increments of $.05 per query. Physician access is anticipated to be at a cost of $60 per month per physician, and every facility will have to give its physicians access to IBM Watson and cloud based healthcare decision support.



Personal, consumer queries are anticipated to account for 93% of the healthcare decision support revenue by 2019. Growth is a result of new cognitive computing technology availability. It is not enough to maintain a static position in a market, nimble competitors steal market share away if innovation is not pursued, this is increasingly true in the healthcare decision support markets. Innovation provides competitive advantage and protection of market position.



Companies Profiled



Market Leaders



McKesson InterQual 

Millman 

IBM

Truven 



Market Participants



Accenture

Aetna

AMD

American Well Systems

Assa Abloy

AT&T

Boehringer Ingelheim

Bosch

Bayer - Viterion

Biotronik

BT

Buccaneer

Cardionet

Centerstone Research Institute

ciCoach.com

Cisco

Cleveland Clinic

CMS

Deutsche Telecom

eCardio Diagnostics

Eliza Corp

EMC 5-24

Healthrageous

Honeywell HomMed

Humedica

GlobalMed

Intel

Kaiser

Mayo Clinic

Medical Strategic Planning

Medullan

NTT

Partners Healthcare

Philips

Polycom

PwC

Qolpac

Qualcomm

Sorin Group

Sotera

Skype

Sony

Sutter Center for Integrated Care

Telecare

Telesofia Medical

Textron Systems

VA Department of Veterans Affairs

Verizon

Vidyo

Walmart

Worksmart



Check Out These Key Topics



IBM Watson Decision Support

Healthcare Decision Support

Clinical decision support

Decision support criteria

Healthcare Coverage

Automates pre-authorization

Automates eligibility

Helathcare network coverage

Payment estimation

Drive real-time diagnostic test selection

Drive real-time diagnostic test coverage

Behavioral Health

Clinical Evidence Summaries

Care Planning

Retrospective Monitoring

Clinical guidelines

Support for Clinician Decisions At The Point Of Care

Continuum of healthcare

Cognitive Computing

End To End Systems

Better Analytics


Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Telematics Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Telematics by the synonym itself defines the integration of telecommunications and information and communications technologies abruptly called as informatics. It can be simply the technology of transmitting, receiving, sending and ...

March 2017 | $4995 | Pre Book Price:$4371

Circulating Tumor Cells Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Circulating tumor cells (CTCs) are cells which detach from its primary or secondary tumors, enters in to the bloodstream and travel to distant organs. This is the evolving field of ...

March 2017 | $4995 | Pre Book Price:$4371

Glycobiology Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

The term glycobiology, also called as glycans, is the study of structure, function and biology of carbohydrate. They are the most essential components in living things. Merton Bernfield and colleagues ...

March 2017 | $4995 | Pre Book Price:$4371

Drug Testing Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Drug testing includes different testing methods which are conducted to detect presence of drugs in the human body. These drugs are tested through blood, sweat, saliva, oral fluid and urine. ...

March 2017 | $4995 | Pre Book Price:$4371

Tissue Engineering and Regeneration Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Tissue engineering is developed from the field of biomaterials development and refers to the practice of combining cells or tissues with biologically active molecules into functional tissues. They are mainly ...

March 2017 | $4995 | Pre Book Price:$4371

Biopsy Devises Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

A biopsy is a medical test, mainly used to detect cancer, performed by surgeons, cardiologist or by radiologist. It involves in the extraction of sample cells or tissues for examination ...

March 2017 | $4995 | Pre Book Price:$4371

2017 © Copyright Big Market Research

View Pricing >>